Interactions between the nitrergic and the endocannabinoid system in rats exposed to the elevated T-maze

被引:0
作者
Batista, Luara Augusta [1 ]
de Araujo Moreira, Fabricio [1 ]
de Aguiar, Daniele Cristina [1 ]
机构
[1] Univ Fed Minas Gerais, Inst Biol Sci, Dept Pharmacol, Belo Horizonte, MG, Brazil
来源
ACTA NEUROPSYCHIATRICA | 2021年 / 33卷 / 04期
基金
巴西圣保罗研究基金会;
关键词
nitric oxide; CB1; receptors; panic; anxiety; cannabinoids; NITRIC-OXIDE SYNTHASE; DORSOLATERAL PERIAQUEDUCTAL GREY; GUANOSINE-MONOPHOSPHATE PATHWAY; STRESS-INDUCED ANXIETY; MODULATION; FEAR; INVOLVEMENT; MORPHINE; RECEPTOR;
D O I
10.1017/neu.2021.7
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Objective: The aim of this study was to test the hypothesis that synthesis of nitric oxide (NO) and activation of CB1 receptors have opposite effects in a behavioural animal model of panic and anxiety. Methods: To test the hypothesis, male Wistar rats were exposed to the elevated T-maze (ETM) model under the following treatments: L-Arginine (L-Arg) was administered before treatment with WIN55,212-2, a CB1 receptor agonist; AM251, a CB1 antagonist, was administered before treatment with L-Arg. All treatments were by intraperitoneal route. Results: The CB1 receptor agonist, WIN55,212-2 (1 mg/kg), induced an anxiolytic-like effect, which was prevented by pretreatment with an ineffective dose of L-Arg (1 mg/kg). Administration of AM251 (1 mg/kg), a CB1 antagonist before treatment with L-Arg (1 mg/kg) did not produce anxiogenic-like responses. Conclusion: Altogether, this study suggests that the anxiolytic-like effect of cannabinoids may occur through modulation of NO signalling.
引用
收藏
页码:206 / 210
页数:5
相关论文
共 27 条
  • [1] The dorsolateral periaqueductal grey N-methyl-D-aspartate/nitric oxide/cyclic guanosine monophosphate pathway modulates the expression of contextual fear conditioning in rats
    Aguiar, Daniele C.
    Hott, Sara C.
    Deolindo, Milena V.
    Guimaraes, Francisco S.
    Resstel, Leonardo B. M.
    [J]. JOURNAL OF PSYCHOPHARMACOLOGY, 2014, 28 (05) : 479 - 485
  • [2] Pharmacological evidence for the role of nitric oxide in the modulation of stress-induced anxiety by morphine in rats
    Anand, Rashmi
    Gulati, Kavita
    Ray, Arunabha
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2012, 676 (1-3) : 71 - 74
  • [3] Role of endocannabinoid signalling in the dorsolateral periaqueductal grey in the modulation of distinct panic-like responses
    Batista, Luara A.
    Bastos, Juliana R.
    Moreira, Fabricio A.
    [J]. JOURNAL OF PSYCHOPHARMACOLOGY, 2015, 29 (03) : 335 - 343
  • [4] Inhibition of endocannabinoid neuronal uptake and hydrolysis as strategies for developing anxiolytic drugs
    Batista, Luara A.
    Gobira, Pedro H.
    Viana, Thercia G.
    Aguiar, Daniele C.
    Moreira, Fabricio A.
    [J]. BEHAVIOURAL PHARMACOLOGY, 2014, 25 (5-6): : 425 - 433
  • [5] NITRIC-OXIDE, A NOVEL NEURONAL MESSENGER
    BREDT, DS
    SNYDER, SH
    [J]. NEURON, 1992, 8 (01) : 3 - 11
  • [6] Nitric oxide may underlie learned fear in the elevated T-maze
    Calixto, AV
    Vandresen, N
    de Nucci, G
    Moreno, H
    Faria, MS
    [J]. BRAIN RESEARCH BULLETIN, 2001, 55 (01) : 37 - 42
  • [7] File Sandra E, 2004, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0803s26
  • [8] Effects of compounds that interfere with the endocannabinoid system on behaviors predictive of anxiolytic and panicolytic activities in the elevated T-maze
    Gobira, Pedro H.
    Aguiar, Daniele C.
    Moreira, Fabricio A.
    [J]. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2013, 110 : 33 - 39
  • [9] The elevated T-maze as an experimental model of anxiety
    Graeff, FG
    Netto, CF
    Zangrossi, H
    [J]. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 1998, 23 (02) : 237 - 246
  • [10] 50 years of hurdles and hope in anxiolytic drug discovery
    Griebel, Guy
    Holmes, Andrew
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2013, 12 (09) : 667 - 687